A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded claims”
...
ALL reports half price - COUPON: 50OFF
Use the code 50OFF to apply the discount on ALL available reports and find what you need to inform every business decision you make.
*Offer expires 23:59 18/06/2019
*If you choose to subscribe to CBD-Intel within 30 days of purchasing one of our reports, we will credit the price of the purchased report to your first year’s subscription.
Start your FREE trial version
Sign up to access to our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
